Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Wealth Enhancement Advisory Services LLC grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 14.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,315 shares of the company’s stock after purchasing an additional 1,030 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Prestige Consumer Healthcare were worth $649,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of PBH. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $7,778,000. Kayne Anderson Rudnick Investment Management LLC purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $84,932,000. Vise Technologies Inc. purchased a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at approximately $319,000. McIlrath & Eck LLC raised its position in shares of Prestige Consumer Healthcare by 19.1% during the 4th quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock valued at $75,000 after buying an additional 154 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Prestige Consumer Healthcare by 24.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 118,113 shares of the company’s stock valued at $9,223,000 after buying an additional 23,334 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 1.1%

Prestige Consumer Healthcare stock opened at $86.59 on Wednesday. Prestige Consumer Healthcare Inc. has a twelve month low of $63.79 and a twelve month high of $90.04. The stock’s fifty day simple moving average is $83.56 and its 200-day simple moving average is $82.54. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm has a market capitalization of $4.28 billion, a P/E ratio of 20.28, a P/E/G ratio of 2.69 and a beta of 0.45.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The business had revenue of $296.52 million for the quarter, compared to analyst estimates of $289.36 million. During the same quarter in the prior year, the company earned $1.02 earnings per share. The company’s revenue was up 7.0% on a year-over-year basis. As a group, equities analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Wall Street Zen raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, May 17th. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a “hold” rating in a research report on Thursday, May 8th. Finally, Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $93.33.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.